Arihant Drugs Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 19-12-2024
- Paid Up Capital ₹ 0.10 M
as on 19-12-2024
- Company Age 32 Year, 3 Months
- Last Filing with ROC 31 Mar 2024
- Revenue %
(FY 2019)
- Profit 146.50%
(FY 2019)
- Ebitda 74.60%
(FY 2019)
- Net Worth 17.97%
(FY 2019)
- Total Assets 11.36%
(FY 2019)
About Arihant Drugs
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Gurumukh Ahuja and Anjali Ahuja serve as directors at the Company.
- CIN/LLPIN
U24232MP1992PTC007302
- Company No.
007302
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
07 Sep 1992
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Gwalior
Industry
Company Details
- Location
Jabalpur, Madhya Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Arihant Drugs?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Gurumukh Ahuja  | Additional Director | 01-Jul-2020 | Current |
| Anjali Ahuja | Additional Director | 01-Jul-2020 | Current |
Financial Performance of Arihant Drugs.
Arihant Drugs Pvt Ltd, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial improvement in profitability, with a 146.5% increase in profit. The company's net worth Soared by an impressive increase of 17.97%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Arihant Drugs?
In 2017, Arihant Drugs had a promoter holding of 51.00% and a public holding of 49.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Unified Web Options And Services Private LimitedActive 4 years 7 months
Gurumukh Ahuja and Anjali Ahuja are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Arihant Drugs?
Unlock and access historical data on people associated with Arihant Drugs, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Arihant Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Arihant Drugs's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
